Ticalopride

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTicalopride
Drug Alias Name替卡必利(+)-NorcisaprideR-149524
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 3 (5-HT3) receptor agonistsSerotonin 4 (5-HT4) receptor agonists
TargetsSerotonin 4 (5-HT4) receptorSerotonin 3 (5-HT3) receptor
Therapy Area/IndicationsGastroesophageal Reflux
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSunovion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson Innovative MedicineSunovion Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsGastroesophageal Reflux

Other Information

ATC CodeN/A
Related LinksDrugBank